• NSC-23766: Rac GTPase Inhibitor for Advanced Cancer Research

  2026-05-05

  NSC23766 trihydrochloride stands out as a highly selective Rac1 signaling pathway inhibitor, empowering researchers to dissect oncogenic mechanisms and induce apoptosis with precision. This article delivers actionable protocols and troubleshooting insights, translating recent high-impact discoveries into robust workflows for cancer and endothelial biology.

• FITC Goat Anti-Rabbit IgG: Precision for Early Biomarker Dis

  2026-05-04

  This thought-leadership article explores the mechanistic, experimental, and strategic dimensions of fluorescent secondary antibody technology—specifically the FITC Goat Anti-Rabbit IgG (H+L) Antibody—in the context of translational biomarker discovery for diseases such as diabetic nephropathy. Integrating the latest quantitative proteomics evidence and workflow best practices, it provides actionable guidance for researchers aiming to achieve high sensitivity, specificity, and reproducibility in immunofluorescence and related assays, while highlighting clinical translation opportunities and current maturity limits.

• Pentoxifylline Suppresses Macrophage Activation via NO Inhib

  2026-05-04

  This reference study demonstrates that pentoxifylline, a broad-spectrum phosphodiesterase inhibitor, suppresses nitric oxide production and activation of macrophages both in vitro and in vivo by elevating intracellular cAMP and downregulating iNOS. The findings clarify the mechanistic role of cAMP elevation in immune regulation and provide a quantitative basis for using pentoxifylline in inflammation research models.

• Dabigatran Etexilate: Clinical Innovation as an Oral Thrombi

  2026-05-03

  This article reviews the pivotal advances of dabigatran etexilate as highlighted in the referenced clinical review, focusing on its innovation as the first oral direct thrombin inhibitor for stroke and VTE prevention. It details the pharmacological benefits, practical limitations, and research implications, bridging experimental insights with translational applications for anticoagulant research.

• PTPN2 Modulates Psoriasis via STING–STAT3 Axis and Autophagy

  2026-05-02

  This reference study uncovers a novel mechanism in which protein tyrosine phosphatase nonreceptor type 2 (PTPN2) alleviates psoriasis by directly targeting the STING–STAT3 axis and restoring autophagy in keratinocytes. The findings highlight PTPN2 as a promising therapeutic target and provide mechanistic insights relevant to STAT3 inhibitor research.

• Applied Cell Cycle Assay Kit Workflows for Phase and Apoptos

  2026-05-02

  The Cell Cycle Assay Kit (Catalog No. K2263) from APExBIO enables precise discrimination of cell cycle phases and robust apoptosis detection, empowering translational cancer research. This article delivers advanced protocol strategies, troubleshooting solutions, and cross-study insights for researchers aiming to achieve reproducible, publication-grade results in cell cycle progression analysis.

• Reserpine (N1867): Technical Guidance for Lab Applications

  2026-05-01

  Reserpine (SKU N1867) addresses the need for a high-purity reagent in neurotransmitter depletion, antihypertensive mechanism, and neuropharmacology studies. This product is not suitable for clinical, diagnostic, or veterinary applications and should be handled strictly within research protocols.

• Notopterol Modulates Macrophage Metabolism to Attenuate Syno

  2026-04-30

  This study reveals that Notopterol, a bioactive compound from Notopterygium incisum, mitigates synovitis in inflammatory arthritis by reprogramming macrophage metabolism through α7 nicotinic acetylcholine receptor (α7nAChR) signaling. These findings highlight the therapeutic potential of targeting macrophage metabolic pathways for modulating inflammation and joint pathology.

• Pentoxifylline in Assisted Male Reproduction: Mechanistic In

  2026-04-30

  This review critically synthesizes recent literature on the in vitro application of pentoxifylline as a phosphodiesterase inhibitor to enhance sperm function in assisted reproductive technologies. The article elucidates pentoxifylline’s mechanistic actions, summarizes controlled findings on motility and acrosome reaction, and discusses practical implications and protocol considerations for fertility researchers.

• Pharmacokinetic Variability of CSBTA Alkaloids in MASH Mice:

  2026-04-29

  This study investigates the pharmacokinetic variability and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in mice with metabolic dysfunction-associated steatohepatitis (MASH). The findings reveal that pathological liver conditions significantly alter the disposition of CSBTA's main active components by modulating drug-metabolizing enzymes and transporters, especially CYP450s and P-glycoprotein, with implications for optimizing dosage regimens in MASH therapy.

• TaqI Restriction Endonuclease: Technical Guidance for Fast D

  2026-04-29

  TaqI Restriction Endonuclease (SKU K3053) provides rapid, reliable cleavage of plasmid, PCR, or genomic DNA for molecular biology workflows where speed and precise sticky end generation are critical. It is not intended for diagnostic or medical applications, and requires adherence to specific storage and buffer handling for optimal results.

• Ceruletide in Pancreatic Function Research: Advanced Protoco

  2026-04-28

  Ceruletide (caerulein) is a gold-standard CCK analog for modeling pancreatic and gastrointestinal physiology. This guide delivers actionable workflows, advanced troubleshooting, and evidence-backed innovations, directly linking recent stem-cell-based breakthroughs to practical in vitro and in vivo assay choices.

• AT13387: Next-Gen Hsp90 Inhibition in Translational Oncology

  2026-04-28

  Explore how AT13387, a next-generation Hsp90 inhibitor from APExBIO, enables new frontiers in cancer biology research. This article bridges mechanistic insight, strategic protocol guidance, and translational relevance—integrating recent discoveries in regulated cell death and NINJ1-mediated DAMP release—to empower researchers targeting oncogenic signaling and apoptosis.

• Honokiol: NF-κB Pathway Inhibitor and Antioxidant for Resear

  2026-04-27

  Honokiol is a small molecule with potent antioxidant, anti-inflammatory, and antiangiogenic activities. Its principal mechanism involves inhibition of NF-κB signaling and scavenging of reactive oxygen species. As supplied by APExBIO (SKU N1672), Honokiol's high purity and solubility in DMSO make it suitable for robust in vitro assays targeting inflammation, oxidative stress, and tumor biology.

• Ciprofloxacin Hydrochloride: Optimizing Antibacterial Workfl

  2026-04-27

  Ciprofloxacin hydrochloride stands out for its dual roles as a fluoroquinolone antibiotic and immunomodulatory agent, enabling advanced experimental designs for DNA replication inhibition and host-pathogen studies. This article breaks down evidence-based workflows, protocol enhancements, and troubleshooting strategies to unlock the full research potential of this compound.

446 records 19/30 page Previous Next First page 上5页 1617181920 下5页 Last page